MedPath

Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa

Phase 2
Completed
Conditions
Immune System Diseases
Interventions
Biological: 10 HEP/mL Betula verrucosa allergen extract
Biological: 25 HEP/mL Betula verrucosa allergen extract
Biological: 50 HEP/mL Betula verrucosa allergen extract
Biological: 100 HEP/mL Betula verrucosa allergen extract
Registration Number
NCT02527187
Lead Sponsor
Inmunotek S.L.
Brief Summary

The main objective is to evaluate the concentration of allergen extract of Betula verrucosa that elicit a papule equivalent to that produced by a solution of histamine dihydrochloride 10 mg / ml in size.

Detailed Description

Open, prospective, unblinded and non-randomized biological assay. Each patient was tested with four concentrations of allergen and with a histamine and saline solution as positive and negative controls, respectively.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
201
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Non-allergic patients to birch pollen10 HEP/mL Betula verrucosa allergen extractPatients already diagnosed to be "true non-allergic" to birch pollen. Non clinical history of symptomatology related to the exposure to birch pollen. Previous skin prick test negative and absence or undetectable serum specific IgE to Betula verrucosa Patients of both gender aged from 5 up to 70 years.
Allergic patients to birch pollen100 HEP/mL Betula verrucosa allergen extractAllergic patients already diagnosed to be "true allergic" to birch pollen. A mean wheal diameter \>3 mm obtained in a prick test with histamine dihydrochloride 10 mg/ml.Also presence of serum specific IgE and clinical history of symptomatology related to exposure to birch pollen. Patients of both gender aged from 5 up to 70 years.
Non-allergic patients to birch pollen100 HEP/mL Betula verrucosa allergen extractPatients already diagnosed to be "true non-allergic" to birch pollen. Non clinical history of symptomatology related to the exposure to birch pollen. Previous skin prick test negative and absence or undetectable serum specific IgE to Betula verrucosa Patients of both gender aged from 5 up to 70 years.
Allergic patients to birch pollen10 HEP/mL Betula verrucosa allergen extractAllergic patients already diagnosed to be "true allergic" to birch pollen. A mean wheal diameter \>3 mm obtained in a prick test with histamine dihydrochloride 10 mg/ml.Also presence of serum specific IgE and clinical history of symptomatology related to exposure to birch pollen. Patients of both gender aged from 5 up to 70 years.
Allergic patients to birch pollen25 HEP/mL Betula verrucosa allergen extractAllergic patients already diagnosed to be "true allergic" to birch pollen. A mean wheal diameter \>3 mm obtained in a prick test with histamine dihydrochloride 10 mg/ml.Also presence of serum specific IgE and clinical history of symptomatology related to exposure to birch pollen. Patients of both gender aged from 5 up to 70 years.
Non-allergic patients to birch pollen50 HEP/mL Betula verrucosa allergen extractPatients already diagnosed to be "true non-allergic" to birch pollen. Non clinical history of symptomatology related to the exposure to birch pollen. Previous skin prick test negative and absence or undetectable serum specific IgE to Betula verrucosa Patients of both gender aged from 5 up to 70 years.
Allergic patients to birch pollen50 HEP/mL Betula verrucosa allergen extractAllergic patients already diagnosed to be "true allergic" to birch pollen. A mean wheal diameter \>3 mm obtained in a prick test with histamine dihydrochloride 10 mg/ml.Also presence of serum specific IgE and clinical history of symptomatology related to exposure to birch pollen. Patients of both gender aged from 5 up to 70 years.
Non-allergic patients to birch pollen25 HEP/mL Betula verrucosa allergen extractPatients already diagnosed to be "true non-allergic" to birch pollen. Non clinical history of symptomatology related to the exposure to birch pollen. Previous skin prick test negative and absence or undetectable serum specific IgE to Betula verrucosa Patients of both gender aged from 5 up to 70 years.
Primary Outcome Measures
NameTimeMethod
Specificity for 50 HEP/mL1 hour

Specificity for 50 HEP/mL concentrations of the pollen of Betula verrucosa allergen extract used in skin prick test.

It is the proportion of negatives that are correctly identified by the test.

Specificity: True negatives/Total no disease.

Sensitivity for 100 HEP/mL1 hour

Sensitivity for 100 HEP/mL concentration of the pollen of Betula verrucosa allergen extract used in skin prick test.

It is the proportion of positives that are correctly identified by the test.

Sensitivity: True positives/Total disease

Sensitivity for 25 HEP/mL1 hour

Sensitivity for 25 HEP/mL concentration of the pollen of Betula verrucosa allergen extract used in skin prick test.

It is the proportion of positives that are correctly identified by the test.

Sensitivity: True positives/Total disease

Sensitivity for 10 HEP/mL1 hour

Sensitivity for 10 HEP/mL concentration of the pollen of Betula verrucosa allergen extract used in skin prick test.

It is the proportion of positives that are correctly identified by the test.

Sensitivity: True positives/Total disease

Sensitivity for 50 HEP/mL1 hour

Sensitivity for 50 HEP/mL concentration of the pollen of Betula verrucosa allergen extract used in skin prick test.

It is the proportion of positives that are correctly identified by the test.

Sensitivity: True positives/Total disease

Specificity for 100 HEP/mL1 hour

Specificity for 100 HEP/mL concentrations of the pollen of Betula verrucosa allergen extract used in skin prick test.

It is the proportion of negatives that are correctly identified by the test.

Specificity: True negatives/Total no disease.

Specificity for 25 HEP/mL1 hour

Specificity for 25 HEP/mL concentrations of the pollen of Betula verrucosa allergen extract used in skin prick test.

It is the proportion of negatives that are correctly identified by the test.

Specificity: True negatives/Total no disease.

Specificity for 10 HEP/mL1 hour

Specificity for 10 HEP/mL concentrations of the pollen of Betula verrucosa allergen extract used in skin prick test.

It is the proportion of negatives that are correctly identified by the test.

Specificity: True negatives/Total no disease.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital Lucus Augusti

šŸ‡ŖšŸ‡ø

Lugo, Galicia, Spain

Ā© Copyright 2025. All Rights Reserved by MedPath